Amber Diversesp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2023-03-10
Share capital
10,000.00 PLN
Registered address
ul. A. Hryniewickiego 10/63a, 81-340 Gdynia, Poland
Electronic delivery address
AE:PL-11190-42324-VTBAG-15
Financials
Revenue history (in k)
Filing timeliness
3 of 3 financial statements were filed late (the longest delay 96 days for 2025).
- 202519/10/2026
- 202419/08/2025
- 202317/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Research and experimental development in natural sciences and engineering104 / 277
Top 38%
Results vs industry
Revenue
This companyUSD 430.58kMedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD 44.17kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 381.19kMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 237.70kMedianUSD 278.35kAverageUSD 8.47m
Industry
Authorized Representatives
Dominik Szymczak – President of the Management Board
Jakub Szymon Koślacz – Management Board Member
Michał Kostowski – Attorney-in-fact (sole)
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jakub Szymon Koślaczage 32 | 50 | $1,350.62 | 50% |
Dominik Szymczakage 32 | 50 | $1,350.62 | 50% |
The articles of association require board approval for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vaxicansp. z o.o. | $390,933.79 | vaxican.com | ||
| Green ZebrasS.A. | $328,658.91 | whygreenzebras.pl | ||
| BiocamS.A. | $327,799.68 | biocam.ai | ||
| Dicellasp. z o.o. | $322,185.03 | dicella.com | ||
| Care Access Polskasp. z o.o. | $305,248.06 | careaccess.pl | ||
| Pharmacy Research Institutesp. z o.o. | $294,406.08 | pharmacyinstitute.pl | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| 4anatropisp. z o.o. | $266,228.34 | 4anatropi.com | ||
| DEBNsp. z o.o. | $247,954.64 | debn.eu | ||
| Gorgon Offshoresp. z o.o. | $132,905.78 | gorgonoffshore.eu |
FAQ
The main business activity of Amber Diverse focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on March 10, 2023.
The headquarters is located at: ul. A. Hryniewickiego 10, 81-340 Gdynia.
The management board includes: Dominik Szymczak (President of the Management Board) and Jakub Szymon Koślacz (Vice President of the Management Board).
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 430,576 in 2025, which is an increase of 40.8% compared to 2024.
Yes, the company recorded a net profit of USD 44,166 in 2025, meaning the company decreased its profit by 39.4%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 157,550 in 2025, representing 41% of all operating expenses.
Last updated: 2026-10-19
